Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer.

Gentile D, Orlandi P, Banchi M, Bocci G.

Med Oncol. 2020 Feb 27;37(3):19. doi: 10.1007/s12032-020-1345-2. Review.

PMID:
32108281
2.

Longitudinal evaluation of angiogenesis-related circulating biomarkers during second-line treatment with paclitaxel and ramucirumab in advanced gastroesophageal cancer.

Fornaro L, Vivaldi C, Orlandi P, Musettini G, Pecora I, Gentile D, Catanese S, Lencioni M, Salani F, Pasquini G, Massa V, Di Desidero T, Falcone A, Vasile E, Bocci G.

Ann Oncol. 2019 Jul;30 Suppl 4:iv88. doi: 10.1093/annonc/mdz155.318. Epub 2019 Dec 4. No abstract available.

PMID:
32085331
3.

Antibiotic resistance and biofilm formation in children with Enteropathogenic Escherichia coli (EPEC) in Brazilian Amazon.

Rodrigues RS, Lima NCDS, Taborda RLM, Esquerdo RP, Gama AR, Nogueira PA, Orlandi PP, Matos NB.

J Infect Dev Ctries. 2019 Aug 31;13(8):698-705. doi: 10.3855/jidc.10674.

4.

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells.

Di Desidero T, Orlandi P, Gentile D, Bocci G.

Front Oncol. 2019 Nov 12;9:1202. doi: 10.3389/fonc.2019.01202. eCollection 2019.

5.

Neglected pulmonary thromboembolism in a traumatic anterior hip dislocation: A case report.

Amendola L, Orlandi PE, Tigani D.

J Clin Orthop Trauma. 2019 Oct;10(Suppl 1):S197-S200. doi: 10.1016/j.jcot.2019.02.005. Epub 2019 Feb 8.

PMID:
31695282
6.

A simple, ex vivo phagocytosis assay of Plasmodium vivax merozoites by flow cytometry.

Farias E, Bezerra F, Baia-da-Silva DC, Chaves YO, Cardoza TB, de Almeida MEM, Oliveira LB, Lalwani P, Orlandi PP, Lacerda MVG, Lopes SCP, Nogueira PA.

Mem Inst Oswaldo Cruz. 2019 Oct 7;114:e190158. doi: 10.1590/0074-02760190158. eCollection 2019.

7.

A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts.

Orlandi PF, Huang J, Fukagawa M, Hoy W, Jha V, Oh KH, Sola L, Cockwell P, Levin A, Feldman HI; iNET-CKD Collaborators.

Kidney Int. 2019 Nov;96(5):1217-1233. doi: 10.1016/j.kint.2019.07.024. Epub 2019 Aug 30.

PMID:
31570197
8.

Antimicrobial properties of α-Ag2WO4 rod-like microcrystals synthesized by sonochemistry and sonochemistry followed by hydrothermal conventional method.

Nobre FX, Bastos IS, Dos Santos Fontenelle RO, Júnior EAA, Takeno ML, Manzato L, de Matos JME, Orlandi PP, de Fátima Souza Mendes J, Brito WR, da Costa Couceiro PR.

Ultrason Sonochem. 2019 Nov;58:104620. doi: 10.1016/j.ultsonch.2019.104620. Epub 2019 May 29.

PMID:
31450327
9.

Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter.

Molinaro A, Orlandi P, Niccolai F, Agretti P, De Marco G, Ferrarini E, Di Cosmo C, Vitti P, Piaggi P, Di Desidero T, Bocci G, Tonacchera M.

J Endocrinol Invest. 2020 Feb;43(2):149-155. doi: 10.1007/s40618-019-01092-9. Epub 2019 Aug 2.

PMID:
31376092
10.

Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation.

Quattrini L, Coviello V, Sartini S, Di Desidero T, Orlandi P, Ke YY, Liu KL, Hsieh HP, Bocci G, La Motta C.

Sci Rep. 2019 Jul 9;9(1):9943. doi: 10.1038/s41598-019-46287-5.

11.

Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells.

Orlandi P, Gentile D, Banchi M, Cucchiara F, Di Desidero T, Cremolini C, Moretto R, Falcone A, Bocci G.

Invest New Drugs. 2020 Feb;38(1):92-98. doi: 10.1007/s10637-019-00804-5. Epub 2019 Jun 1.

PMID:
31154566
12.

Antimicrobial substances from Amazonian Aniba (Lauraceae) species.

da Silva YC, Silva EMS, Fernandes NS, Lopes NL, Orlandi PP, Nakamura CV, Costa EV, da Veiga Júnior VF.

Nat Prod Res. 2019 Apr 16:1-4. doi: 10.1080/14786419.2019.1603225. [Epub ahead of print]

PMID:
30990331
13.

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics.

Di Desidero T, Orlandi P, Fioravanti A, Alì G, Cremolini C, Loupakis F, Gentile D, Banchi M, Cucchiara F, Antoniotti C, Masi G, Fontanini G, Falcone A, Bocci G.

Biochem Pharmacol. 2019 Jun;164:94-105. doi: 10.1016/j.bcp.2019.04.001. Epub 2019 Apr 3.

PMID:
30953637
14.

CHARACTERIZATION OF ENTEROAGGREGATIVE ESCHERICHIA COLI AMONG DIARRHEAL CHILDRENIN WESTERN BRAZILIAN AMAZON.

Taborda RLM, Silva LAD, Orlandi PP, Batista FS, Rodrigues RS, Matos NB.

Arq Gastroenterol. 2018 Oct-Dec;55(4):390-396. doi: 10.1590/S0004-2803.201800000-84.

15.

Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Orlandi PF, Fujii N, Roy J, Chen HY, Lee Hamm L, Sondheimer JH, He J, Fischer MJ, Rincon-Choles H, Krishnan G, Townsend R, Shafi T, Hsu CY, Kusek JW, Daugirdas JT, Feldman HI; CRIC Study Investigators.

BMC Nephrol. 2018 Jun 26;19(1):150. doi: 10.1186/s12882-018-0951-0.

16.

Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors.

Orlandi P, Di Desidero T, Salvia G, Muscatello B, Francia G, Bocci G.

Biochem Pharmacol. 2018 Jun;152:327-337. doi: 10.1016/j.bcp.2018.04.011. Epub 2018 Apr 13.

PMID:
29660315
17.

Assessment of the orthogonal and non-orthogonal coupled-mode theory for parallel optical waveguide couplers.

Bellanca G, Orlandi P, Bassi P.

J Opt Soc Am A Opt Image Sci Vis. 2018 Apr 1;35(4):577-585. doi: 10.1364/JOSAA.35.000577.

PMID:
29603940
18.

Appropriateness and yield of surveillance colonoscopy in first-degree relatives of colorectal cancer patients: A 5-year follow-up population-based study.

Armelao F, Pertile R, Miori G, Franch R, Avancini I, Meggio A, Franceschini G, Pravadelli C, Tieppo C, Faitini K, Giacomin D, Orlandi PG, Tasini E, de Pretis G.

Dig Liver Dis. 2018 May;50(5):475-481. doi: 10.1016/j.dld.2018.02.007. Epub 2018 Feb 21.

PMID:
29544764
19.

Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.

Ferrari SM, Bocci G, Di Desidero T, Ruffilli I, Elia G, Ragusa F, Fioravanti A, Orlandi P, Paparo SR, Patrizio A, Piaggi S, La Motta C, Ulisse S, Baldini E, Materazzi G, Miccoli P, Antonelli A, Fallahi P.

Oncol Rep. 2018 May;39(5):2306-2314. doi: 10.3892/or.2018.6305. Epub 2018 Mar 8.

PMID:
29517106
20.

Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.

Ferrari SM, Bocci G, Di Desidero T, Elia G, Ruffilli I, Ragusa F, Orlandi P, Paparo SR, Patrizio A, Piaggi S, La Motta C, Ulisse S, Baldini E, Materazzi G, Miccoli P, Antonelli A, Fallahi P.

Oncol Rep. 2018 May;39(5):2225-2234. doi: 10.3892/or.2018.6306. Epub 2018 Mar 8.

PMID:
29517103
21.

Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients.

Di Desidero T, Orlandi P, Fioravanti A, Cremolini C, Loupakis F, Marmorino F, Antoniotti C, Masi G, Lonardi S, Bergamo F, Zagonel V, Falcone A, Bocci G.

Invest New Drugs. 2018 Aug;36(4):709-714. doi: 10.1007/s10637-018-0579-8. Epub 2018 Feb 27.

PMID:
29488048
22.

A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis.

Cangussu ASR, Mariúba LAM, Lalwani P, Pereira KDES, Astolphi-Filho S, Orlandi PP, Epiphanio S, Viana KF, Ribeiro MFB, Silva HM, Marinho CRF, Nogueira PA.

Vet Res. 2018 Jan 19;49(1):6. doi: 10.1186/s13567-018-0503-4.

23.

Matricellular proteins and survival in patients with pancreatic cancer: A systematic review.

Fiorino S, Bacchi-Reggiani ML, Birtolo C, Acquaviva G, Visani M, Fornelli A, Masetti M, Tura A, Sbrignadello S, Grizzi F, Patrinicola F, Zanello M, Mastrangelo L, Lombardi R, Benini C, Di Tommaso L, Bondi A, Monetti F, Siopis E, Orlandi PE, Imbriani M, Fabbri C, Giovanelli S, Domanico A, Accogli E, Di Saverio S, Grifoni D, Cennamo V, Leandri P, Jovine E, de Biase D.

Pancreatology. 2018 Jan;18(1):122-132. doi: 10.1016/j.pan.2017.11.001. Epub 2017 Nov 4. Review.

PMID:
29137857
24.

Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy.

Pasqualetti F, Gonnelli A, Cantarella M, Delishaj D, Molinari A, Ortenzi V, Carbone F, Montrone S, Ursino S, Franceschi S, Morganti R, Orlandi P, Di Desidero T, Mazzanti CM, Zavaglia K, Naccarato AG, Bocci G, Paiar F.

Invest New Drugs. 2018 Apr;36(2):340-345. doi: 10.1007/s10637-017-0516-2. Epub 2017 Sep 30.

PMID:
28965273
25.

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer.

Di Desidero T, Antonelli A, Orlandi P, Ferrari SM, Fioravanti A, Alì G, Fontanini G, Basolo F, Francia G, Bocci G.

Cancer Lett. 2017 Dec 28;411:35-43. doi: 10.1016/j.canlet.2017.09.032. Epub 2017 Sep 28.

PMID:
28964784
26.

Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.

Vaglini F, Pardini C, Di Desidero T, Orlandi P, Pasqualetti F, Ottani A, Pacini S, Giuliani D, Guarini S, Bocci G.

Mol Neurobiol. 2018 Jun;55(6):4984-4997. doi: 10.1007/s12035-017-0702-4. Epub 2017 Aug 8.

PMID:
28791594
27.

A Bayesian approach to model the conditional correlation between several diagnostic tests and various replicated subjects measurements.

Pereira da Silva HD, Ascaso C, Gonçalves AQ, Orlandi PP, Abellana R.

Stat Med. 2017 Sep 10;36(20):3154-3170. doi: 10.1002/sim.7339. Epub 2017 May 21.

PMID:
28543307
28.

Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.

Pasqualetti F, Orlandi P, Simeon V, Cantarella M, Giuliani D, Di Desidero T, Gonnelli A, Delishaj D, Lombardi G, Sechi A, Sanson M, Zagonel V, Paiar F, Danesi R, Guarini S, Bocci G.

Mol Neurobiol. 2018 Feb;55(2):1396-1404. doi: 10.1007/s12035-017-0414-9. Epub 2017 Feb 1.

PMID:
28150230
29.

Simultaneous, But Not Consecutive, Combination With Folinate Salts Potentiates 5-Fluorouracil Antitumor Activity In Vitro and In Vivo.

Di Paolo A, Orlandi P, Di Desidero T, Danesi R, Bocci G.

Oncol Res. 2017 Aug 7;25(7):1129-1140. doi: 10.3727/096504017X14841698396900. Epub 2017 Jan 20.

PMID:
28109077
30.

International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts.

Dienemann T, Fujii N, Orlandi P, Nessel L, Furth SL, Hoy WE, Matsuo S, Mayer G, Methven S, Schaefer F, Schaeffner ES, Solá L, Stengel B, Wanner C, Zhang L, Levin A, Eckardt KU, Feldman HI.

BMC Nephrol. 2016 Sep 2;17(1):121. doi: 10.1186/s12882-016-0335-2.

31.

Immune response pattern in recurrent Plasmodium vivax malaria.

Chaves YO, da Costa AG, Pereira ML, de Lacerda MV, Coelho-Dos-Reis JG, Martins-Filho OA, Teixeira-Carvalho A, Malheiro A, Monteiro WM, Orlandi PP, Marinho CR, Nogueira PA.

Malar J. 2016 Aug 31;15(1):445. doi: 10.1186/s12936-016-1501-5.

32.

Multidrug resistant Pseudomonas aeruginosa survey in a stream receiving effluents from ineffective wastewater hospital plants.

Magalhães MJ, Pontes G, Serra PT, Balieiro A, Castro D, Pieri FA, Crainey JL, Nogueira PA, Orlandi PP.

BMC Microbiol. 2016 Aug 24;16(1):193. doi: 10.1186/s12866-016-0798-0.

33.

Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients.

Di Desidero T, Derosa L, Galli L, Orlandi P, Fontana A, Fioravanti A, Marconcini R, Giorgi M, Campi B, Saba A, Lucchesi S, Felipetto R, Danesi R, Francia G, Allegrini G, Falcone A, Bocci G.

Invest New Drugs. 2016 Dec;34(6):760-770. Epub 2016 Aug 24.

PMID:
27557783
34.

A new protoparvovirus in human fecal samples and cutaneous T cell lymphomas (mycosis fungoides).

Phan TG, Dreno B, da Costa AC, Li L, Orlandi P, Deng X, Kapusinszky B, Siqueira J, Knol AC, Halary F, Dantal J, Alexander KA, Pesavento PA, Delwart E.

Virology. 2016 Sep;496:299-305. doi: 10.1016/j.virol.2016.06.013. Epub 2016 Jul 7.

35.

1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions.

Coviello V, Marchi B, Sartini S, Quattrini L, Marini AM, Simorini F, Taliani S, Salerno S, Orlandi P, Fioravanti A, Desidero TD, Vullo D, Da Settimo F, Supuran CT, Bocci G, La Motta C.

J Med Chem. 2016 Jul 14;59(13):6547-52. doi: 10.1021/acs.jmedchem.6b00616. Epub 2016 Jun 27.

PMID:
27305384
36.

Phenotypic and Molecular Aspects of Staphylococcus spp. Isolated from Hospitalized Patients and Beef in the Brazilian Amazon.

Pieri FA, Vargas TF, Galvão NN, Nogueira PA, Orlandi PP.

Foodborne Pathog Dis. 2016 Mar;13(3):128-34. doi: 10.1089/fpd.2015.2049. Epub 2016 Jan 29.

PMID:
26824600
37.

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration.

Lazzeri S, Orlandi P, Piaggi P, Sartini MS, Casini G, Guidi G, Figus M, Fioravanti A, Di Desidero T, Ripandelli G, Parravano M, Varano M, Nardi M, Bocci G.

Pharmacogenomics. 2016;17(1):35-9. doi: 10.2217/pgs.15.153. Epub 2015 Dec 14.

PMID:
26653034
38.

Proteomic analysis of Chromobacterium violaceum and its adaptability to stress.

Castro D, Cordeiro IB, Taquita P, Eberlin MN, Garcia JS, Souza GH, Arruda MA, Andrade EV, Filho SA, Crainey JL, Lozano LL, Nogueira PA, Orlandi PP.

BMC Microbiol. 2015 Dec 1;15:272. doi: 10.1186/s12866-015-0606-2.

39.

Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward.

Lazzeri S, Ripandelli G, Sartini MS, Parravano M, Varano M, Nardi M, Di Desidero T, Orlandi P, Bocci G.

Angiogenesis. 2015 Oct;18(4):397-432. doi: 10.1007/s10456-015-9483-4. Epub 2015 Sep 7. Review.

PMID:
26346237
40.

Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.

Solini A, Simeon V, Derosa L, Orlandi P, Rossi C, Fontana A, Galli L, Di Desidero T, Fioravanti A, Lucchesi S, Coltelli L, Ginocchi L, Allegrini G, Danesi R, Falcone A, Bocci G.

Oncotarget. 2015 Oct 6;6(30):28743-54. doi: 10.18632/oncotarget.4926.

41.

Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2.

Salerno S, Marini AM, Fornaciari G, Simorini F, La Motta C, Taliani S, Sartini S, Da Settimo F, García-Argáez AN, Gia O, Cosconati S, Novellino E, D'Ocon P, Fioravanti A, Orlandi P, Bocci G, Dalla Via L.

Eur J Med Chem. 2015 Oct 20;103:29-43. doi: 10.1016/j.ejmech.2015.08.027. Epub 2015 Aug 14.

PMID:
26318056
42.

Adherence and virulence genes of Escherichia coli from children diarrhoea in the Brazilian Amazon.

Benevides-Matos N, Pieri FA, Penatti M, Orlandi PP.

Braz J Microbiol. 2015 Mar 1;46(1):131-7. doi: 10.1590/S1517-838246120130917. eCollection 2015 Mar.

43.

Long-term outcomes of elderly kidney transplant recipients.

Orlandi PF, Cristelli MP, Aldworth CA, Freitas TV, Felipe CR, Silva Junior HT, Pestana JO.

J Bras Nefrol. 2015 Apr-Jun;37(2):212-20. doi: 10.5935/0101-2800.20150034. English, Portuguese.

44.

Small circular single stranded DNA viral genomes in unexplained cases of human encephalitis, diarrhea, and in untreated sewage.

Phan TG, Mori D, Deng X, Rajindrajith S, Ranawaka U, Fan Ng TF, Bucardo-Rivera F, Orlandi P, Ahmed K, Delwart E.

Virology. 2015 Aug;482:98-104. doi: 10.1016/j.virol.2015.03.011. Epub 2015 Apr 1.

45.

Evaluation of rapid screening techniques for detection of Salmonella spp. from produce samples after pre-enrichment according to FDA BAM and a short secondary enrichment.

Yoshitomi KJ, Jinneman KC, Orlandi PA, Weagant SD, Zapata R, Fedio WM.

Lett Appl Microbiol. 2015 Jul;61(1):7-12. doi: 10.1111/lam.12422. Epub 2015 Apr 30.

46.

Inertial waves and mean velocity profiles in a rotating pipe and a circular annulus with axial flow.

Yang Y, Ostilla-Mónico R, Wu J, Orlandi P.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 Jan;91(1):013015. Epub 2015 Jan 30.

PMID:
25679716
47.

Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab.

Allegrini G, Coltelli L, Orlandi P, Fontana A, Camerini A, Ferro A, Cazzaniga M, Casadei V, Lucchesi S, Bona E, Di Lieto M, Pazzagli I, Villa F, Amoroso D, Scalese M, Arrighi G, Molinaro S, Fioravanti A, Finale C, Triolo R, Di Desidero T, Donati S, Marcucci L, Goletti O, Del Re M, Salvadori B, Ferrarini I, Danesi R, Falcone A, Bocci G.

Pharmacogenomics. 2014 Dec;15(16):1985-99. doi: 10.2217/pgs.14.140.

PMID:
25521357
48.

Antimicrobial activity of allylic thiocyanates derived from the Morita-Baylis-Hillman reaction.

Sá MM, Ferreira M, Lima ES, dos Santos I, Orlandi PP, Fernandes L.

Braz J Microbiol. 2014 Oct 9;45(3):807-12. eCollection 2014.

49.

Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients.

Derosa L, Galli L, Orlandi P, Fioravanti A, Di Desidero T, Fontana A, Antonuzzo A, Biasco E, Farnesi A, Marconcini R, Francia G, Danesi R, Falcone A, Bocci G.

Cancer. 2014 Dec 15;120(24):3923-31. doi: 10.1002/cncr.28953. Epub 2014 Aug 8.

50.

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo.

Antonelli A, Bocci G, La Motta C, Ferrari SM, Fallahi P, Corrado A, Fioravanti A, Sartini S, Orlandi P, Piaggi S, Corti A, Materazzi G, Galleri D, Ulisse S, Fontanini G, Danesi R, Da Settimo F, Miccoli P.

Mol Cell Endocrinol. 2014 Aug 5;393(1-2):56-64. doi: 10.1016/j.mce.2014.06.002. Epub 2014 Jun 12.

PMID:
24931161

Supplemental Content

Loading ...
Support Center